The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned. 23andMe has been testing the waters for a buyer ...

(JTA) — The genetic testing company 23andMe is facing a class action lawsuit over its security practices after hackers stole and published data about 1 million people with Jewish ancestry.

Few companies had a year as bumpy as 23andMe had in 2024, with the company settling a lawsuit related to a data breach and announcing a round of layoffs. Amid that turmoil, many of the popular ...

The genetic testing company 23andMe has agreed to pay $30 million to American plaintiffs to settle a lawsuit over a data breach last year that specifically targeted customers of Ashkenazi Jewish ...

Wojcicki last spring first offered to buy the company and take it public. Anne Wojcicki, the CEO of pioneering genetic testing company 23andMe, is open again to a third-party takeover of the company.

Genetic testing firm 23andMe (NASDAQ:ME) said it formed a special board committee to review strategic alternatives. The special committee will look at options including a sale, business ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year ...

The Board of Directors of 23andMe previously formed the Special Committee, which is comprised of independent directors, to review strategic alternatives that may be available to 23andMe. The ...

Now, an alliance between Novartis and genetic testing specialist 23andMe is trying to encourage greater awareness of Lp(a) and improve testing rates. The pilot programme will see a confidential ...

23andMe Holding Co. has introduced Discover23®, a new research platform allowing authorized partners to securely access a vast array of genetic data through a Trusted Research Environment (TRE ...